Healthcare

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

CAMBRIDGE, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a…

2 months ago

Decimal.health Appoints Diana Gelston as President and Managing Partner to Lead the Company’s Next Phase of Growth

BOSTON, MA / ACCESS Newswire / October 16, 2025 / Decimal.health today announced the appointment of Diana Gelston as President…

2 months ago

HopeHealth Launches Phase 3 Clinical Trial Site To Advance Lupus Research With Support From Bristol Myers Squibb

First HopeHealth Clinical Trial Marks Major Milestone for Access to Medical Research in Rural South CarolinaOriginally published on HopeHealth NORTHAMPTON,…

2 months ago

Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace

Odyssey Medical Devices, Inc., a subsidiary of Odyssey Health Inc., to acquire exclusive global marketing and distribution rights for the…

2 months ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY®…

2 months ago

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation’s Most Trusted Health Care Distributors- Relationship…

2 months ago

Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board

NEEDHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage…

2 months ago

Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland

FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device…

2 months ago

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement

CHICAGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated…

2 months ago

National PKU Alliance Grant Advances Engineered Native Bacteria Candidate for Phenylketonuria (PKU)

San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics,…

2 months ago